Department of Internal Medicine, Division of Endocrinology and Metabolism, UT Southwestern Medical Center, Dallas, TX, USA.
Rev Endocr Metab Disord. 2018 Sep;19(3):227-230. doi: 10.1007/s11154-018-9458-z.
There has been an increasing prevalence of individuals presenting for treatment of gender dysphoria over the past several years. This growing population includes transgender children referred to pediatric clinics. Transgender children meeting diagnostic criteria for gender dysphoria, with supportive mental health care, may be treated with gonadotropin releasing hormone (GnRH) agonists and cross sex hormones. The treatment for these children requires ongoing maintenance and monitoring and therefore follow-up in the adult care setting. As is the case with other conditions that require long term treatment, these youth need a formal transition from pediatric to adult clinical care. The period of transition of care is critical and if not executed properly exposes the adolescent to risks of complications, and loss of follow-up. The proper clinical transfer is especially important for transgender youth in the setting of increased psychosocial and mental health issues. The transition of care for transgender adolescents has not been formally studied but given a growing population seeking treatment for gender dysphoria, it will need to be systematically assessed to determine the best outcomes to measure.
在过去的几年中,越来越多的人因性别焦虑前来接受治疗。这一不断增长的群体包括被转介到儿科诊所的跨性别儿童。符合性别焦虑症诊断标准、并获得心理健康支持的跨性别儿童,可以接受促性腺激素释放激素(GnRH)激动剂和跨性别激素治疗。这些儿童的治疗需要持续的维持和监测,因此需要在成人护理环境中进行随访。与其他需要长期治疗的疾病一样,这些年轻人需要从儿科临床护理正式过渡到成人临床护理。护理过渡期至关重要,如果处理不当,会使青少年面临并发症和随访丢失的风险。对于存在较多社会心理和心理健康问题的跨性别青年来说,适当的临床转介尤其重要。跨性别青少年的护理过渡期尚未得到正式研究,但鉴于越来越多的人寻求治疗性别焦虑症,需要对其进行系统评估,以确定最佳的衡量指标。